Bruker Announces Order for 10 NMR Systems to Enable World-Class Scientific Research at King Abdullah University of Science & ...

  
    
  
  
    
      Bruker BioSpin announces today that it has received an order from King 
      Abdullah University of Science and Technology (KAUST) for ten (10) 
      Nuclear Magnetic Resonance (NMR) spectrometers valued at close to $20 
      million, including Bruker’s flagship 950 MHz superconducting NMR magnet. 
      KAUST is a new graduate-level research university in Saudi Arabia, 
      dedicated to inspiring a new age of scientific achievement and the 
      realization of a vision of King Abdullah.
    
    
      The two-story, eight-ton 950 MHz magnet is the world’s highest-field 
      superconducting actively shielded high-resolution NMR magnet system. The 
      heart of this 950 MHz NMR magnet is a proprietary coil set made of about 
      100 miles of superconducting wire which is producing a 22.3 Tesla 
      magnetic field. The large magnet will allow scientists to investigate 
      the structure of bio-molecules and study their interactions with greater 
      resolution and sensitivity than ever before.
    
    
      The 950 MHz magnet at the center of KAUST’s NMR facility will be 
      surrounded by other Bruker NMR spectrometers, ranging from 400 MHz for 
      chemistry up to an actively-shielded 850 MHz widebore magnet for 
      solid-state NMR. All Bruker NMR systems ordered will include the Bruker 
      next-generation Avance™ III NMR console, which incorporates 
      second-generation (2G) digital receiver (DR) technology for a 
      significant further improvement in NMR detection fidelity. This 2G-DR 
      technology and Bruker’s leading NMR probe and CryoProbe™ technology 
      provide a new level of performance for demanding NMR experiments in 
      structural biology, chemistry and material sciences.
    
    
      The broad range of NMR systems ordered will enable KAUST to offer 
      leading-edge capabilities for NMR research to its scientists and 
      academic partners. Installation of these NMR systems is expected to 
      begin in 2009 and to continue into 2010, with many of them targeted to 
      be operational for the planned opening of KAUST in September 2009.
    
    
      “We look forward at KAUST to exploit the advanced capabilities of the 
      NMR systems manufactured by Bruker,” stated Dr. Mohamed E. Samaha, 
      interim VP for Research at KAUST. “These systems will be utilized to 
      expand the boundaries of the scientific knowledge. They are an integral 
      constituent to realize King Abdullah’s vision and our overall plans to 
      build one of the world’s leading scientific research institutions for 
      the prosperity and development of Saudi Arabia and the world.”
    
    
      ABOUT BRUKER BIOSPIN
    
    
      For more information about Bruker BioSpin and Bruker Corporation 
      (NASDAQ: BRKR), please visit www.bruker-biospin.com 
      and www.bruker.com.
    
    
      CAUTIONARY STATEMENT
    
    
      Any statements contained in this press release that do not describe 
      historical facts may constitute forward-looking statements as that term 
      is defined in the Private Securities Litigation Reform Act of 1995. Any 
      forward-looking statements contained herein are based on current 
      expectations, but are subject to a number of risks and uncertainties. 
      The factors that could cause actual future results to differ materially 
      from current expectations include, but are not limited to, risks and 
      uncertainties relating to the integration of businesses we have acquired 
      or may acquire in the future, changing technologies, product development 
      and market acceptance of our products, the cost and pricing of our 
      products, manufacturing, competition, dependence on collaborative 
      partners and key suppliers, capital spending and government funding 
      policies, changes in governmental regulations, intellectual property 
      rights, litigation, and exposure to foreign currency fluctuations. These 
      and other factors are identified and described in more detail in our 
      filings with the SEC, including, without limitation, our annual report 
      on Form 10-K for the year ended December 31, 2007, our most recent 
      quarterly reports on Form 10-Q and our current reports on Form 8-K. We 
      disclaim any intent or obligation to update these forward-looking 
      statements other than as required by law.